Dr. Kim Eagle provides a weekly tip for clinicians on the front lines of the COVID-19 pandemic. This week's tip provides an interim update on the Oxford COVID (ChAdOx1 nCoV-19) vaccine (https://www.acc.org/latest-in-cardiol...).
The ACC's Sandra J. Lewis Cardiovascular Women's Leadership Institute will support the unique needs of mid-career women as they continue to sustain and grow their leadership skills. Part of the ACC's Campaign for the Future, the Institute will further the College's Strategic Goals to foster a diverse pipeline of leaders within the profession and the ACC itself. "For many women, 15 to 20 years into their career, changes in responsibilities serve as an opportunity to reassess, reimagine and reinvent their professional lives," says Sandra J. Lewis, MD, FACC, whose transformational gift to the Campaign for the Future is making the Institute possible. "While this stage may serve as a professional renaissance for many, it is also a stage with opportunities for unique guidance and targeted leadership development to successfully transition forward 'to the next'.” Read more: http://bit.ly/2KefKk1#ACCFuture#ACCWIC
Watch a COVID-19: Protecting Patients at Greatest Risk mini-course for NCD Academy on “Building Back Better to Put People First in the NCD Response: Views From Africa and the Middle East.” Learn more about the NCD Academy by visiting ACC.org/NCDAcademy.
Watch a COVID-19: Protecting Patients at Greatest Risk mini-course for NCD Academy on “Building Back Better to Put People First in the NCD Response.” Learn more about the NCD Academy by visiting ACC.org/NCDAcademy.
Watch a COVID-19: Protecting Patients at Greatest Risk mini-course for NCD Academy on “Building Back Better to Put People First in the NCD Response: Views From Asia.” Learn more about the NCD Academy by visiting ACC.org/NCDAcademy.
Watch a COVID-19: Protecting Patients at Greatest Risk mini-course for NCD Academy on “Building Back Better to Put People First in the NCD Response: Views From Latin America.” Learn more about the NCD Academy by visiting ACC.org/NCDAcademy.
Dr. Kim Eagle provides a weekly tip for clinicians on the front lines of the COVID-19 pandemic. This week's tip focuses on the WHO Solidarity trial (https://www.acc.org/latest-in-cardiol...) and whether COVID-19 drugs (i.e., remdesivir, hydroxychloroquine
JACC: Heart Failure Editor-in-Chief Christopher O’Connor, MD, MACC; authors G. Michael Felker, MD, MHS, FACC, and John J.V. McMurray, MD, FACC; and Journal editors discussion on the manuscript, “Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study.
Editorial board members from JACC: Case Reports, JACC: Cardiovascular Imaging, and JACC: Cardiovascular Interventions host a joint Virtual Journal Club discussing research on valvular heart disease and structural interventions. JACC: Case Reports Editor-in-Chief Julia Grapsa, MD, Ph.D., FACC, moderates the event, and panelists include William A. Zoghbi, MD, MACC; Nicolo Piazza, MD, Ph.D., FACC; Nadeen N. Faza, MD, FACC; Edgar Argulian, MD; Maurizio Taramasso, MD, Ph.D.; and Rafael Vidal Pérez, MD, Ph.D.
Non-communicable diseases are Mexico’s biggest killers, and people living in rural areas are most at risk – due to a lack of medical technology and health care workers with the right training. Watch a video to learn how an online academy is helping doctors all over the country give their communities the support they need.
Get more information on the NCD Academy or download the app at ncdacademy.acc.org.
This video was produced for the American College of Cardiology, in partnership with NCD Alliance, World Heart Federation, and Viatris Inc., by BBC StoryWorks, the commercial content division of BBC Global News.
Hani Najm, MD, FACC, Chair of the ACC Assembly of International Governors, shares why he believes providing opportunities for young physicians around the world to come to the United States for exposure to cardiovascular clinicians is one way to achieve the ACC’s Campaign for the Future’s goal to improve heart health around the world. Dr. Najm is proud to sponsor the Hani Najm Global Scholar Awards, which will allow two early career cardiologists from the Middle East and North Africa to come to the U.S. for an observership at a major health system and attend that year’s Annual Scientific Session. According to Dr. Najm, “Sharing knowledge is the best way to combat the increasing prevalence of cardiovascular disease around the world.” Get involved in ACC’s Campaign for the Future at https://www.ACC.org/Future
Dr. Kim Eagle provides a weekly tip for clinicians on the front lines of the COVID-19 pandemic. JAMA Network Open (https://www.acc.org/latest-in-cardiol...) examines a potential increase in risk of Multisystem Inflammatory Syndrome observed in Black and Latino children.
John Gordon Harold, MD, MACC, ACC past president and chair of ACC’s Campaign for the Future, announces the public launch of the ACC's Campaign for the Future – a Mission-based philanthropic effort to empower future cardiovascular leaders, researchers, and clinicians; build a diverse and inclusive profession; and foster innovation and grow transformational global programs aimed at optimizing patient care and improving outcomes. According to Harold, “The Campaign for the Future is an important opportunity for ACC members worldwide to not only help shape the future of our profession but also build on the legacy of those cardiovascular giants who have come before.” Get involved at https://www.ACC.org/Future
ACC President Athena Poppas, MD, FACC, reflects on 2020 and shares her gratitude for how the global cardiovascular profession has come together to fight COVID-19, to stand against racism and violence, to promote diversity and inclusion in our workforce, and to address disparities in the health care system. “Together we have risen to every occasion in 2020 and together we will come out on the other side stronger and better prepared for future challenges,” she said. “I have never been prouder to be a part of the ACC and the larger cardiovascular community.” https://bit.ly/3m20ZOU
Listen to Expert Faculty discuss how to incorporate the use of GLP-1 RA and SGLT2 inhibitors into your healthcare setting in a multidisciplinary way. This discussion focuses on how to identify the key team members, how to communicate effectively across the care team, and how important education is on the successful collaboration across the care team continuum.
Listen to Expert Faculty discuss the paradigm shift for cardiologists in understanding how to use SGLT2i's and GLP-1RA's safely and effectively in their practice. This discussion focuses on when and how to safely commence these drugs, as well as when and how to engage other members of the care team.
Listen to Expert Faculty discuss the fundamental science and the mechanism to evidence around new antihyperglycemic drugs, and why exactly this is such an important topic. This conversation focuses on the key principles of adding GLP-1 RAs and SGLT2 inhibitors, and how using these drugs has been shown to have an important effect on reducing cardiovascular outcomes.
Drs. Peter Block, Deepak Bhatt, and Kim Eagle look back on Day 5 of AHA 2020 late-breaking science and featured clinical research, including results from the INVESTED trial (0:30). Visit https://www.acc.org/aha2020 for full meeting coverage.
Drs. Peter Block, Deepak Bhatt, and Kim Eagle look back on Day 4 of AHA 2020 late-breaking science and featured clinical research, including SEARCH-AF (0:33), FIDELIO (2:09), THALES (3:17), RHAPSODY (5:11), SOLOIST-WHF (7:08), and SCORED (9:01). Visit https://www.acc.org/aha2020 for full meeting coverage.
Dr. Kim Eagle and Dr. Deepak Bhatt look back on Day 3 of AHA 2020 late-breaking science and featured clinical research, including STRENGTH (0:55), OMEMI (0:55), EXPLORER-HCM (7:56), One-Month DAPT (9:48), and COLCOT Diabetes (14:42). Visit https://www.acc.org/aha2020 for full meeting coverage.
Dr. Kim Eagle and Dr. Deepak Bhatt look back on Day 2 of AHA 2020 late-breaking science and featured clinical research, including ALPHEUS (0:50) and RIVER (5:51). Visit https://www.acc.org/aha2020 for full meeting coverage.
Dr. Kim Eagle and Dr. Deepak Bhatt look back on Day 1 of AHA 2020 late-breaking science and featured clinical research, including GALACTIC-HF (0:47), AFFIRM-AHF (2:49), VITAL-Rhythm (4:42), ARREST (6:35), TIPS-3 (8:54), DAPA-CKD (12:34), and EMPEROR-Reduced (12:34). Visit https://www.acc.org/aha2020 for full meeting coverage.
Dr. Kim Eagle provides a weekly tip for clinicians on the front lines of the COVID-19 pandemic. This week's tip focuses on the impact of prior HF on hospitalized COVID-19 patients (https://www.acc.org/latest-in-cardiol...) and what clinicians can do to mitigate the risk in this population.